Physician

Abdulwahhab Alroaini, M.D.

According to 2025 Medicare claims, Abdulwahhab Alroaini, M.D. (NPI: 1598968547) practices cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is ADVANCED HEART & VASCULAR CARE PLLC (NPI: 1437511573; TIN: 473273458) and primary practice location at 48192-4668. Alroaini is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Alroaini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 989 traditional Medicare patients, billed 3,156 HCPCS/CPT codes, and received $202,088 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,349 prescription claims across 486 beneficiaries totaling $642,867 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 11 claims. Open Payments data shows 54 records totaling $1,435. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $273,997 and ending at $202,088. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $55,847 to $642,867. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,214	3,024	$273,997
2016	1,020	2,340	$223,244
2017	626	1,863	$150,690
2018	893	2,252	$165,308
2019	1,299	3,180	$217,889
2020	1,237	3,554	$252,115
2021	1,395	3,917	$277,004
2022	1,206	3,339	$225,526
2023	1,076	3,308	$225,995
2024	989	3,156	$202,088

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	1,198	$55,847
2016	230	1,488	$87,493
2017	255	1,558	$117,588
2018	269	1,834	$165,579
2019	304	1,938	$182,182
2020	354	2,370	$312,641
2021	394	2,790	$422,920
2022	407	2,808	$504,454
2023	461	3,090	$608,758
2024	486	3,349	$642,867

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$25,600
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	189	197	$104
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	311	315	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	341	766	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	257	375	$62
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	268	381	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	183	12,345	$227,142
Xarelto	Rivaroxaban	100	6,060	$109,345
Brilinta	Ticagrelor	126	7,412	$103,477
Entresto	Sacubitril/Valsartan	68	3,457	$74,860
Repatha Sureclick	Evolocumab	37	1,890	$34,892

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,435	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdulwahhab Alroaini, M.D.?

Tedicare shows public-source Medicare data for Abdulwahhab Alroaini, M.D. (NPI 1598968547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdulwahhab Alroaini, M.D. have ACO affiliation data?

Abdulwahhab Alroaini, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Abdulwahhab Alroaini, M.D.?

Abdulwahhab Alroaini, M.D. is linked to ADVANCED HEART & VASCULAR CARE PLLC (billing NPI 1437511573) in the available physician profile data.

Does Abdulwahhab Alroaini, M.D. have Open Payments data?

Abdulwahhab Alroaini, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.